NAVELBINE Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Navelbine, and when can generic versions of Navelbine launch?

Navelbine is a drug marketed by Pierre Fabre and is included in one NDA.

The generic ingredient in NAVELBINE is vinorelbine tartrate. There are fifteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the vinorelbine tartrate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Navelbine

A generic version of NAVELBINE was approved as vinorelbine tartrate by HIKMA on June 10^th, 2003.

Subscribe

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for NAVELBINE?
What are the global sales for NAVELBINE?
What is Average Wholesale Price for NAVELBINE?

Summary for NAVELBINE

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	45
Clinical Trials:	136
Patent Applications:	3,823
Drug Prices:	Drug price information for NAVELBINE
What excipients (inactive ingredients) are in NAVELBINE?	NAVELBINE excipients list
DailyMed Link:	NAVELBINE at DailyMed

Drug patent expirations by year for NAVELBINE

Recent Clinical Trials for NAVELBINE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
St. Jude Children's Research Hospital	Phase 1/Phase 2
Guangdong Provincial People's Hospital	Phase 2
First Affiliated Hospital, Sun Yat-Sen University	Phase 2

See all NAVELBINE clinical trials

US Patents and Regulatory Information for NAVELBINE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pierre Fabre	NAVELBINE	vinorelbine tartrate	INJECTABLE;INJECTION	020388-001	Dec 23, 1994		DISCN	Yes	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for NAVELBINE

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pierre Fabre	NAVELBINE	vinorelbine tartrate	INJECTABLE;INJECTION	020388-001	Dec 23, 1994	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for NAVELBINE

See the table below for patents covering NAVELBINE around the world.

Subscribe to access the full database, or Subscribe
Country	Patent Number	Title	Estimated Expiration
Netherlands	990027		⤷ Subscribe
Japan	S6332795		⤷ Subscribe
France	2434171		⤷ Subscribe
Canada	1136129	COMPOSES INTERMEDIAIRES UTILES DANS LA SYNTHESE DE DERIVES BIS-INDOLIQUES ET PROCEDE POUR LEUR PREPARATION (INTERMEDIATES USED FOR THE SYNTHESIS OF BIS-INDOLIC DERIVATIVES AND PROCESS FOR THEIR PREPARATION)	⤷ Subscribe
France	2434172		⤷ Subscribe
France	2448545		⤷ Subscribe
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for NAVELBINE

Subscribe to access the full database, or Subscribe
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0010458	SPC/GB96/037	United Kingdom	⤷ Subscribe	SPC/GB96/037, EXPIRES: 20040410
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

AI Research Assistant

Questions you can ask:

Summary for NAVELBINE

Recent Clinical Trials for NAVELBINE

Make Better Decisions: Try a trial or see plans & pricing